Construction and application of pancreatic exocrine organoid and spheroid for drug screening and precision medicine
Frontiers in Cell and Developmental Biology · 06.01.2026 · 13
DOI: 10.3389/fcell.2025.1746622 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.01.2026. Verfasst von Xin Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The incidence of pancreatic exocrine disorders, particularly pancreatic cancer, has been steadily rising. However, treatment options remain limited, with substantial interindividual variability in therapeutic efficacy. This clinical challenge has accelerated the development of advanced three-dimensional (3D) modeling systems, with patient-derived organoids and multicellular spheroids emerging as transformative tools that faithfully recapitulate tumor pathophysiology. In contrast to 2D cultures, which fail to recapitulate the three-dimensional spatial architecture and cell-cell interactions found in vivo , these models have gained prominence in pancreatic cancer research due to their unique capacity to: (1) precisely mimic the tumor microenvironment (TME), (2) preserve tumor heterogeneity, and (3) enable rapid establishment. This review systematically examines current methodologies for constructing pancreatic exocrine 3D models, their integration with bioengineering platforms for drug screening, and innovative applications in multi-omics-driven precision medicine. We further evaluate the translational potential of these systems in clinical decision-making and discuss how they may reshape therapeutic paradigms for pancreatic diseases, offering new avenues for personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
- Shanghai Institute of Pancreatic Diseases, Shanghai, China.
- National Key Labotatory of Immunity and Inflammation, Naval Medical University, Shanghai, China.
- Department of Gastroenterology, No. 981 Hospital of the PLA, Chengde, Hebei, China.
Zitieren
APA
Tan, X., Huang, B., Yang, X., Wang, P., & Hu, L. (2026). Construction and application of pancreatic exocrine organoid and spheroid for drug screening and precision medicine. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1746622
Vancouver
Tan X, Huang B, Yang X, Wang P, Hu L. Construction and application of pancreatic exocrine organoid and spheroid for drug screening and precision medicine. Frontiers in Cell and Developmental Biology. 2026;13. doi:10.3389/fcell.2025.1746622
BibTeX
@article{Tan2026,
author = {Tan, Xin and Huang, Bangwei and Yang, Xinyi and Wang, Pengyuan and Hu, Lianghao},
title = {Construction and application of pancreatic exocrine organoid and spheroid for drug screening and precision medicine},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {13},
doi = {10.3389/fcell.2025.1746622}
}
EUVIMED